Lanean...
Comparison of outcomes of HCT in blast phase of BCR-ABL1(−) MPN with de novo AML and with AML following MDS
Comparative outcomes of allogeneic hematopoietic cell transplantation (HCT) for BCR-ABL1(−) myeloproliferative neoplasms (MPNs) in blast phase (MPN-BP) vs de novo acute myeloid leukemia (AML), and AML with prior myelodysplastic syndromes (MDSs; post-MDS AML), are unknown. Using the Center for Intern...
Gorde:
| Argitaratua izan da: | Blood Adv |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society of Hematology
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556156/ https://ncbi.nlm.nih.gov/pubmed/33007075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002621 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|